EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Instil Bio's enterprise value is $8.77 Mil.
Instil Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, Instil Bio's EV-to-Revenue for today is .
The historical rank and industry rank for Instil Bio's EV-to-Revenue or its related term are showing as below:
During the past 5 years, the highest EV-to-Revenue of Instil Bio was 46266.95. The lowest was -10072.89. And the median was -226.34.
TIL's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.95 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-14), Instil Bio's stock price is $11.88.
Instil Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Therefore, Instil Bio's PS Ratio for today is .
Instil Bio EV-to-Revenue Historical Data
The historical data trend for Instil Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Instil Bio's EV-to-Revenue
For the Biotechnology subindustry, Instil Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instil Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Instil Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Instil Bio's EV-to-Revenue falls into.
Instil Bio's current Enterprise Value is $8.77 Mil.
Instil Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instil Bio's share price for today is $11.88.
Instil Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instil Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Instil Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing an innovative cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using our Co-Stimulatory Antigen Receptor, or CoStAR, platform. The company's lead product candidate, ITIL-168, is an autologous TIL therapy that it is initially developing for the treatment of PD-1-inhibitor relapsed or refractory advanced melanoma.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TIL has been successfully added to your 